Mediterranean diet adherence was linked with better quality of life in some autoimmune conditions
A review found more encouraging quality-of-life results than inflammation results, with confidence varying by condition and study design.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Closer adherence to a Mediterranean diet was associated with better quality of life in multiple sclerosis and celiac disease, with less certain evidence in rheumatoid arthritis. Inflammation findings were inconsistent. Because the review mixed randomized and observational research, these results do not establish that the diet causes the same benefits across autoimmune conditions.
This abstract-based summary provides no effect sizes, study durations, or condition-specific intervention details. The review rated the overall evidence as limited, with inconsistent, low-certainty findings for the inflammation marker C-reactive protein.
Different designs answer different questions
The review combined randomized trials, observational studies, and studies comparing participants before and after an intervention. This mix captures different kinds of evidence, so an association with dietary adherence is not automatically evidence of a treatment effect.
Results varied by condition
Quality-of-life evidence was rated moderately certain for multiple sclerosis and celiac disease, and less certain for rheumatoid arthritis. A single cohort reported lower mortality in Crohn's disease and inflammatory bowel disease; this remains observational evidence.
The original publication
Effects of the Mediterranean diet on inflammation, quality of life, and mortality in autoimmune diseases: A systematic review featured in the Italian National Guidelines "La Dieta Mediterranea".
Gianfredi V, Baldini L, Deledda A et al.
Nutrition · 2026
- PubMed ID
- 41386096
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.